IDH2 and central nervous system cancer: Many gliomas, especially oligodendrogliomas, have mutations in isocitrate dehydrogenase 1 (IDH1) or isocitrate dehydrogenase 2 (IDH2), as well as deletions of chromosome arms 1p and 19q [29,30].